KH001

DRUG5 trials

Sponsors

HysensBio Co., Ltd, Byoung-Moo Seo, Seoul National University Dental Hospital

Conditions

Dental CariesDentin CariesDentin HypersensitivityDentin Sensitivity

Phase 1

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

CompletedNCT04804514

HysensBio Co., LtdDentin Sensitivity

Start: 2021-06-14End: 2023-03-03Updated: 2025-02-26

Phase 2

A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

CompletedNCT06264453

HysensBio Co., LtdDentin Hypersensitivity

Start: 2024-03-19End: 2024-09-25Updated: 2025-03-14

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

CompletedNCT06464939

HysensBio Co., LtdDentin Hypersensitivity

Start: 2024-10-08End: 2025-12-22Updated: 2026-01-13

A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries

CompletedNCT06580678

Byoung-Moo SeoDentin Caries

Start: 2024-11-06End: 2025-05-07Updated: 2026-01-13

A Clinical Study of KH001 for Pulp Preservation and Safety in Deep Dentin Caries

Not yet recruitingNCT07751016

Seoul National University Dental HospitalDental Caries

Start: 2026-09-30End: 2028-06-30Target: 36Updated: 2026-08-06